Galderma Group AG (SWX:GALD)

Switzerland · Delayed Price · Currency is CHF

173.65

+4.35 (2.57%)

Jul 24, 2026, 5:30 PM CET

Galderma Group AG Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Revenue	5,923	5,241	4,440	4,117
Revenue Growth	13.01%	18.04%	7.85%	-
Gross Profit	4,113	3,609	3,085	2,885
Operating Income	1,101	829	645	536
Net Income	863	613	231	-57
Earnings Per Share	3.65	2.58	0.97	-0.24
EPS Growth	41.47%	165.98%	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Neuromodulators	1,590	1,471	1,285	1,162	1,002	792.9
Fillers & Biostimulators	1,178	1,101	1,014	966	990.1	881.1
Dermatological Skincare	1,578	1,449	1,331	1,212	1,089	861
Therapeutic Dermatology	1,544	1,185	780	741.7	679.4	882
Revenue (Total)	5,923	5,241	4,440	4,117	-	-

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Investments	839	780	457	368
Total Debt	2,717	2,755	2,761	4,919
Net Cash (Debt)	-1,878	-1,975	-2,304	-4,551
Net Cash Growth	-	-	-	-
Net Cash Per Share	-7.97	-8.33	-9.69	-19.16

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Operating Cash Flow	1,206	1,185	488	165
Capital Expenditures	-126	-113	-128	-121
Free Cash Flow	1,080	1,072	360	44
Free Cash Flow Growth	0.75%	197.78%	718.18%	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Gross Margin	69.44%	68.86%	69.48%	70.08%
Operating Margin	18.59%	15.82%	14.53%	13.02%
Pretax Margin	15.85%	12.17%	6.98%	0.27%
Profit Margin	14.57%	11.70%	5.20%	-1.38%
FCF Margin	18.23%	20.45%	8.11%	1.07%

Dividends

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Jul '26 Jul 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Dividend Per Share	0.350	0.441	0.166
Dividend Per Share Growth	0%	166.65%	-
Dividend Yield	0.20%	0.08%	-

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023
Period Ending	Jul '26 Jul 26, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
PE Ratio	84.88	79.34	-	-
Forward PE	38.59	49.03	43.27	-
P/FCF Ratio	47.92	44.79	-	-
PS Ratio	9.80	9.16	-	-